The coronavirus pandemic had an immediate impact on biopharmaceutical industry supply chains. Drug firms struggled to find materials, technologies and third-party capacity.
But as the emergency continued, they found ways of adapting to the changed environment. Digital tech enabled this change and is set to shape the industry for years to come.
Learn more 👉 https://bit.ly/3VweXdL